Variables | Incontinence statusb | ||
---|---|---|---|
Continent | Incontinent | ||
(n = 78) | (n = 235) | ||
Proportion of patients having OAB-related hospitalization experience during the past 12 months‡ | USA | 1 (5.0%) | 3 (4.6%) |
Europe | 9 (15.8%) | 31 (18.2%) | |
Total | 10 (12.8%) | 34 (14.5%) | |
Proportion of patients that ever had OAB-related surgery‡ | USA | 2 (9.5%) | 10 (15.9%) |
Europe | 6 (10.5%) | 11 (6.5%) | |
Total | 8 (10.3%) | 21 (9.1%) | |
Proportion of patients that had switched anticholinergics used for OAB due to efficacy/side effects‡ | USA | 6 (28.6%) | 15 (23.1%) |
Europe | 18 (31.6%) | 46 (27.1%) | |
Total | 24 (30.8%) | 61 (26.0%) | |
Proportion of patients currently using pads (at the time of completing the survey) ‡ | USA** | 4 (19.0%) | 40 (61.5%) |
Europe*** | 6 (10.5%) | 127 (75.6%) | |
Total*** | 10 (12.8%) | 167 (71.7%) | |
Number of OAB-related physician visits over the past 3 months‡‡ | USA | 1.3 (1.2) | 1.5 (1.3) |
Europe | 2.2 (2.4) | 2.5 (2.3) | |
Total | 2.0 (2.1) | 2.2 (2.0) | |
Number of pads used per week‡‡ | USA | 4.5 (12.2) | 10.8 (14.4) |
Europe*** | 0.8 (2.4) | 9.3 (9.0) | |
Total*** | 1.8 (6.7) | 9.7 (10.8) |